Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Electroacupuncture inhibits astrocyte activation and alleviates neuroinflammation in rats with ischemic stroke based on JAK2/STAT3 signaling pathway].

Created on 19 Nov 2026

Authors

Wenlong Hua, Zheng Zhou, Siliang Li, Wei Lan, Yuqing Jiang, Feng Qiao, Mengjie Sun, Hui Li, Wei Tang

Published in

Zhen ci yan jiu = Acupuncture research. Volume 51. Issue 11. Pages 1472-1481. Nov 25, 2026.

Abstract

To investigate the effect of electroacupuncture (EA) intervention on neuroinflammatory response in rats with ischemic stroke by modulating astrocyte activation, based on the Janus kinase 2(JAK2)/signal transducer and activator of transcription 3(STAT3) signaling pathway.
Forty-five male SD rats were randomly selected as the sham operation group. The ischemic stroke model was established by occlusion of the middle cerebral artery by referring to the modified Zea Longa's suture-occlusion method. Ninety successfully modeled rats were randomly assigned to model group and EA group which were further divided into subgroups based on the intervention time points (1, 3 and 7 d). For rats of the EA group, EA (2 Hz/10 Hz, 1.5 mA) was applied to "Baihui" (GV20) and "Dazhui" (GV14) for 20 min (starting from 2 h post-modeling), once daily for 1, 3 or 7 d. The modified neurological severity score (mNSS) was used to assess neurological deficits, and 2, 3, 5-Triphenyltetrazolium chloride (TTC) staining was employed to measure the cerebral infarction volume. Hematoxylin and Eosin (H&E) staining was used to observe histopathological changes in the ischemic cortex. The protein expression levels of glial fibrillary acidic protein (GFAP), JAK2, STAT3, phosphorylated-JAK2 (p-JAK2), p-STAT3, complement component 3 (C3), and S100 calcium-binding protein A10 (S100A10) in the ischemic brain tissue were detected using Western blot. The contents of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6 in the ischemic brain tissue were determined using enzyme-linked immunosorbent assay (ELISA). The mRNA expression levels of GFAP, JAK2, and STAT3 in the ischemic brain tissue were detected by using quantitative real-time PCR. The double-staining immunofluorescence intensity of GFAP and STAT3 of the ischemic brain tissue was determined using immunofluorescence staining.
Compared with the sham operation group, the model group showed a significant increase in cerebral infarction volume (P<0.01), and mNSS, protein expression levels of GFAP, JAK2, STAT3, p-JAK2, p-STAT3, and C3, contents of TNF-α, IL-1β, and IL-6 and mRNA expression levels of GFAP, JAK2 and STAT3 at the 1st, 3rd and 7th day (P<0.01), and the immunofluorescence intensity of GFAP and STAT3 co-staining (P<0.01), and a significant reduction in the expression of S100A10 at the 1st, 3rd and 7th day (P<0.01). The ischemic cortex exhibited severe neuronal structural damage, characterized by obvious nuclear pyknosis, cellular swelling and rupture, disordered axonal arrangement and vacuolar changes. After EA intervention, all the increased and decreased levels of the indexes mentioned above were reversed (P<0.05, P<0.01), including obvious improvement of morphology of neurons in the ischemic cortex, characterized by more regular cell arrangement and clearer cellular nucleus. Compared with the group receiving EA for 1 d, the group with 7 d of EA treatment exhibited lower protein expression levels of GFAP, C3 and S100A10 as well as decreased contents of TNF-α, IL-1β and IL-6 (P<0.01), while the group receiving EA for 3 d showed up-regulated S100A10 protein expression (P<0.05).
EA can improve neurological deficits and reduce cerebral ischemic volume in ischemic stroke rats, which may be related to its functions in inhibiting the activation of the JAK2/STAT3 signaling pathway, mitigating neuroinflammation response mediated by excessive astrocyte activation, and the effects are time-dependent.

PMID:
43051691
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement